Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People

NACompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Hypertension, SystolicCerebrovascular Disease
Interventions
OTHER

Anti-hypertensive therapy to SBP 130 mm Hg

Anti-hypertensive therapy to achieve 24 hour systolic blood pressure less than or equal to 130 mm Hg

OTHER

Anti-hypertensive therapy to SBP 145 mm Hg

Anti-hypertensive therapy to achieve 24 hour systolic blood pressure less than or equal to 145 mm Hg

Trial Locations (1)

06030

University of Connecticut Health Center, Farmington

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

UConn Health

OTHER

NCT01650402 - Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People | Biotech Hunter | Biotech Hunter